Global Drugs for Schistosomiasis Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Drugs for Schistosomiasis market size will reach 98.59 Million USD in 2025 and is projected to reach 130.17 Million USD by 2032, with a CAGR of 4.05% (2025-2032). Notably, the China Drugs for Schistosomiasis market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Drugs for schistosomiasis are medications used to treat infections caused by parasitic worms of the Schistosoma genus. Praziquantel is the primary drug employed for treating all forms of schistosomiasis, a neglected tropical disease prevalent in areas with inadequate sanitation and freshwater exposure. Praziquantel targets the adult parasites, causing muscle paralysis and eventual death, allowing the body to eliminate them. The drug's effectiveness has made it a cornerstone of schistosomiasis control and elimination efforts. Given the disease's impact on millions of people, especially in Africa, praziquantel distribution and treatment campaigns are crucial components of public health strategies to combat schistosomiasis and reduce its health and socioeconomic burden.
The major global suppliers of Drugs for Schistosomiasis include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Drugs for Schistosomiasis. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Drugs for Schistosomiasis market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Drugs for Schistosomiasis market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Schistosomiasis industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Drugs for Schistosomiasis Include:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Drugs for Schistosomiasis Product Segment Include:
Praziquantel
Oxamniquine
Others
Drugs for Schistosomiasis Product Application Include:
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Drugs for Schistosomiasis Industry PESTEL Analysis
Chapter 3: Global Drugs for Schistosomiasis Industry Porter's Five Forces Analysis
Chapter 4: Global Drugs for Schistosomiasis Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Drugs for Schistosomiasis Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Drugs for Schistosomiasis Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Drugs for Schistosomiasis Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Drugs for Schistosomiasis market size will reach 98.59 Million USD in 2025 and is projected to reach 130.17 Million USD by 2032, with a CAGR of 4.05% (2025-2032). Notably, the China Drugs for Schistosomiasis market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Drugs for schistosomiasis are medications used to treat infections caused by parasitic worms of the Schistosoma genus. Praziquantel is the primary drug employed for treating all forms of schistosomiasis, a neglected tropical disease prevalent in areas with inadequate sanitation and freshwater exposure. Praziquantel targets the adult parasites, causing muscle paralysis and eventual death, allowing the body to eliminate them. The drug's effectiveness has made it a cornerstone of schistosomiasis control and elimination efforts. Given the disease's impact on millions of people, especially in Africa, praziquantel distribution and treatment campaigns are crucial components of public health strategies to combat schistosomiasis and reduce its health and socioeconomic burden.
The major global suppliers of Drugs for Schistosomiasis include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Drugs for Schistosomiasis. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Drugs for Schistosomiasis market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Drugs for Schistosomiasis market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Schistosomiasis industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Drugs for Schistosomiasis Include:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Drugs for Schistosomiasis Product Segment Include:
Praziquantel
Oxamniquine
Others
Drugs for Schistosomiasis Product Application Include:
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Drugs for Schistosomiasis Industry PESTEL Analysis
Chapter 3: Global Drugs for Schistosomiasis Industry Porter's Five Forces Analysis
Chapter 4: Global Drugs for Schistosomiasis Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Drugs for Schistosomiasis Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Drugs for Schistosomiasis Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Drugs for Schistosomiasis Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Drugs for Schistosomiasis Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Drugs for Schistosomiasis Product by Type
- 1.2.1 Praziquantel
- 1.2.2 Oxamniquine
- 1.2.3 Others
- 1.3 Drugs for Schistosomiasis Product by Application
- 1.3.1 S. haematobium
- 1.3.2 S. mansoni
- 1.3.3 S. japonicum
- 1.3.4 S. mekongi
- 1.3.5 S. intercalatum
- 1.4 Global Drugs for Schistosomiasis Market Size Analysis (2020-2032)
- 1.5 Drugs for Schistosomiasis Market Development Status and Trends
- 1.5.1 Drugs for Schistosomiasis Industry Development Status Analysis
- 1.5.2 Drugs for Schistosomiasis Industry Development Trends Analysis
- 2 Drugs for Schistosomiasis Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Drugs for Schistosomiasis Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Drugs for Schistosomiasis Market Analysis by Country
- 4.1 Global Drugs for Schistosomiasis Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Drugs for Schistosomiasis Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Drugs for Schistosomiasis Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.5 China Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.6 France Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.14 India Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Drugs for Schistosomiasis Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Drugs for Schistosomiasis Market Revenue by Key Suppliers (2021-2025)
- 5.2 Drugs for Schistosomiasis Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Drugs for Schistosomiasis Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Drugs for Schistosomiasis Market Analysis by Type
- 6.1 Global Drugs for Schistosomiasis Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Drugs for Schistosomiasis Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Shin Poong
- 7.1.1 Shin Poong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Shin Poong Drugs for Schistosomiasis Product Portfolio
- 7.1.3 Shin Poong Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Merck
- 7.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Merck Drugs for Schistosomiasis Product Portfolio
- 7.2.3 Merck Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Bayer
- 7.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Bayer Drugs for Schistosomiasis Product Portfolio
- 7.3.3 Bayer Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 EIPICO
- 7.4.1 EIPICO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 EIPICO Drugs for Schistosomiasis Product Portfolio
- 7.4.3 EIPICO Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Chandra Bhagat Pharma
- 7.5.1 Chandra Bhagat Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio
- 7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Taj Pharmaceuticals
- 7.6.1 Taj Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio
- 7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Drugs for Schistosomiasis Industry Chain Analysis
- 8.2 Drugs for Schistosomiasis Product Downstream Application Analysis
- 8.2.1 Global Drugs for Schistosomiasis Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Drugs for Schistosomiasis Revenue and Forecast by Application (2020-2032)
- 8.3 Drugs for Schistosomiasis Typical Downstream Customers
- 8.4 Drugs for Schistosomiasis Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
